Peter Marks
US tells J&J millions of vaccine doses from troubled plant can’t be used
The U.S. Food and Drug Administration said on June 11 it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can't be used because of possible contamination issues.
US pauses J&J vaccine in blow to global immunization drive
U.S. health authorities have recommended pausing the Johnson & Johnson COVID-19 shot over blood clot fears, with the company announcing it would delay its European rollout in a setback for global immunization efforts.